TENS and Neuropathic Pain — What the Evidence Shows
GreatHealthGear synthesises published research and independent clinical literature. We do not conduct our own testing.
The evidence base for TENS in neuropathic pain is more complex than for musculoskeletal pain:
- Diabetic peripheral neuropathy: Several RCTs and a 2017 systematic review (Jin et al., Journal of Diabetes Research) found TENS reduces pain intensity compared to sham, with modest effect sizes. Evidence is considered supportive but not definitive.
- Post-herpetic neuralgia: Some evidence supports high-frequency conventional TENS for PHN pain relief. The sensitised nature of post-herpetic tissue requires careful intensity calibration — start low.
- Sciatica / radiculopathy: Clinical TENS use for sciatica is common. Research shows variable results — acute sciatica from disc herniation may respond differently to chronic sciatic pain from spinal stenosis.
- Chemotherapy-induced peripheral neuropathy (CIPN): Emerging evidence from small studies suggests TENS may reduce CIPN pain intensity. Clinical supervision is particularly important in this context.
How to Choose a TENS Unit for Nerve Pain
Programme breadth matters more for nerve pain than for musculoskeletal pain. Neuropathic responses to TENS are highly individual — the mode that works for one person’s sciatica may do nothing for another’s. Devices with more programmes (TechCare Plus 24 with 24, iReliev with 14) give more opportunities to find the effective mode.
Dual-channel coverage is useful for extended nerve distributions. Sciatica running from the lumbar spine to the calf requires coverage over a long nerve path — two channels allow simultaneous paravertebral and leg placement.
Work with a healthcare professional. Neuropathic pain is more complex than muscle pain, and optimal electrode placement for specific nerve presentations often requires physiotherapy or pain specialist guidance. The devices in this guide are tools — a professional assessment of your placement is worth doing.